Please ensure Javascript is enabled for purposes of website accessibility

House Passes SAFE Banking Act to Protect Banks and Cannabis Companies

By Rich Duprey - Apr 20, 2021 at 10:36AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Will the fourth time be the charm?

Legitimate cannabis producers and related businesses would no longer be treated like illegal operations in the financial world if a bill that was passed Monday evening by the House of Representatives becomes law.

The Secure and Fair Enforcement Banking Act -- aka, the SAFE Banking Act -- would open up financing and allow banks to establish relationships with marijuana businesses operating in states that have legalized the plant for medicinal or recreational purposes. The measure specifically prevents federal regulators from sanctioning banks and other financial institutions that do business with such companies. The bill passed the House 321 to 101.

Marijuana on $100 bills

Image source: Getty Images.

Even though a majority of U.S. states have legalized marijuana for some uses, it remains a Class I controlled substance at the federal level. As such, banks are prevented from lending to companies operating cannabis businesses, or even letting them establish bank accounts.

This has meant the companies are forced to deal in cash, including paying their employees, which increases the risks of crime against them and their workers. It also hinders their growth.

Multistate operators like Cresco Labs (CRLBF -0.28%), Green Thumb Industries (GTBIF 2.86%), and Trulieve Cannabis (TCNNF -2.71%) would likely be the immediate beneficiaries of the SAFE Banking Act, though Canadian producers such as Aphria (APHA), Cronos Group (CRON -1.94%), and Tilray (TLRY) would undoubtedly see benefits down the road.

Yet the Act's prospects in the Senate are uncertain. Monday's vote marks the fourth time the SAFE Banking Act has passed the House. It was first approved in 2019, and then twice more when its provisions were included in larger coronavirus relief bills. In all three cases, the then-Republican-controlled Senate blocked it.

With Democrats now in control of the upper house, legal marijuana companies theoretically have a better chance to see the bill pass this time around.

Rich Duprey has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Cresco Labs Inc., Green Thumb Industries, and Trulieve Cannabis Corp. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Tilray Stock Quote
Cronos Group Stock Quote
Cronos Group
$3.03 (-1.94%) $0.06
Green Thumb Industries Stock Quote
Green Thumb Industries
$10.42 (2.86%) $0.29
Aphria Stock Quote
Trulieve Cannabis Stock Quote
Trulieve Cannabis
$12.92 (-2.71%) $0.36
Cresco Labs Inc. Stock Quote
Cresco Labs Inc.
$3.52 (-0.28%) $0.01

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/11/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.